Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
about
Identification of Epstein-Barr Virus Replication Proteins in Burkitt's Lymphoma Cells.Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma.Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor.Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes.Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.Induction of interferon-stimulated genes on the IL-4 response axis by Epstein-Barr virus infected human b cells; relevance to cellular transformation.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsEpstein-Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression.EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latencyHost Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript RegionMemory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation eventImmune Evasion by B-cell Lymphoma.Innate immune responses against Epstein Barr virus infectionOncogenic mechanisms in Burkitt lymphomaImmune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunityRepression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.Epstein-Barr virus: novel patented therapeutics.Epidemiology: clues to the pathogenesis of Burkitt lymphoma.EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infectionModes of infection and oncogenesis by the Epstein-Barr virus.The Epstein-Barr virus and the pathogenesis of lymphoma.Epstein-Barr virus and Burkitt lymphoma.Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells.Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.Current Trends and Alternative Scenarios in EBV Research.Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2.The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathwaysSudden unexpected death due to hemophagocytic lymphohistiocytosis syndrome.A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal.The genetic diversity of Epstein-Barr virus in the setting of transplantation relative to non-transplant settings: A feasibility study.Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome.EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA.Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.Epstein-Barr virus (EBV) association and latency profile in pediatric Burkitt's lymphoma: experience of a single institution in Argentina.IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells.Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
P2860
Q30488509-86F022F4-2183-40F4-BBF8-54FCFF8FDFE3Q33735916-394384CB-8687-4C80-B1BE-3994A4593C70Q34055803-B02DB858-BC26-40DA-9DFA-F1A673493783Q34071474-43E2FC10-4352-49A4-9F05-70B13A6FDD81Q34106764-C488401F-687D-4384-8858-B774F442C0C6Q34283174-AF024C20-07EB-4D55-8DFF-553A5AB339B7Q34749867-DD1DFF20-6DA3-4BA9-88DF-9A05B728DFCDQ35232848-0487621B-D8F6-4589-BD0A-588CF5EC6B80Q35476446-7DF4DD6A-765A-4E41-8A7F-F483F675A82BQ35932258-27BCD0BF-3FF5-4DE1-936D-083498278668Q36281868-84374B29-43F7-439B-9BFC-26057EB044EFQ36519976-04087701-9E45-445F-AE87-73B4FB7F3939Q36541271-3E5A753A-1435-4C64-9658-A9FE7ABC56EBQ37309928-4FBA7FE8-76B7-40B7-9CBB-659354B8E973Q37522401-F9E05C49-B182-436D-B294-0ED30A432E3FQ37652046-8D1F1ACC-24FC-4D8D-991E-3D0E579DE906Q37713998-F3591DE4-F2D6-479D-927F-0EB21EA54972Q37729167-5796E5C9-5B53-45C1-94A2-B864A09B2A64Q37977130-AA3EAD39-1F75-4826-ABF9-FE387FE3D6AAQ38156169-F2947913-D14E-4268-B609-F95C7F8EED3BQ38191876-5E6B7D9F-79E9-4BF2-9ED9-ECA25A5FEEB3Q38258049-91757A2D-ABF0-4BAC-83F0-D4F53E9080ACQ38270680-3C7F19C9-A25A-44FD-9FBF-6C4924A2EC3FQ38321333-4AD18835-02D5-4B5B-9127-67BA584A2BA6Q38768957-D51A1BBB-2115-47CC-A2D3-D8C7068D5B54Q38962956-5017EBC4-8C87-4AAE-8BD0-9ACF5FB85F8AQ39016336-0B25B25F-E5C1-43D9-8B9B-E0009235E463Q39344864-C3EC7818-68A4-49A7-9591-E1ABB42FAE27Q39625133-4554A1D6-6CF8-4E87-914A-3F18DB68CFE1Q40247439-54FF7CC4-CED5-41BB-9B52-5BFE6A1364C4Q40288450-9820A24A-4979-4294-AF58-BD82EC63B002Q40310879-64FD7D09-261A-47F9-ABFC-96611C21063FQ40605557-06B61AF4-3BD8-44C1-A20E-5B8D264C11C9Q41464136-ED6C45AA-9DF9-4A9A-9B67-EBDFA2BE5C56Q41807836-FA6D30F6-3A7D-444D-9203-A4E75A1CC395Q42220952-9871BCE1-9144-410D-993C-106A8424808EQ42270362-8F098220-C570-412E-B5BB-99E6AFAB519AQ44267868-1168BDB5-ECDA-44F9-9042-1F8053D56D4EQ45354727-4EAE9AD2-9466-481B-A1DB-2CE3002E3D5E
P2860
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@ast
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@en
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@nl
type
label
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@ast
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@en
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@nl
prefLabel
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@ast
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@en
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
@nl
P2860
P921
P1476
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology
@en
P2093
Alan B Rickinson
Gemma L Kelly
P2860
P304
P356
10.1016/J.SEMCANCER.2009.07.004
P5008
P577
2009-07-18T00:00:00Z